首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells
【24h】

Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells

机译:子宫内膜异位症患者S100A6的上调及其在异位子宫内膜基质细胞中的作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

S100 calcium-binding protein A6 (S100A6) is up-regulated in many malignancies and overexpression of S100A6 has been identified associated with proliferation, migration and invasion phenotype in several cancer cells. In the present study, we explored whether S100A6 plays a role in the development of endometriosis. Significantly higher levels of mRNA and protein expression of S100A6 were observed in ectopic endometrial tissues compared to eutopic and normal endometrial tissues. Silencing of S100A6 in ectopic endometrial stromal cells (ESCs) significantly inhibited cell viability, migration and invasion. Moreover, knockdown of S100A6 suppressed p38/MAPK activity in ectopic ESCs, which can be partially attenuated by CacyBP/SIP phosphorylation inhibitor. In conclusion, our results suggest that the abnormal expression of S100A6 may contribute to the pathogenesis of endometriosis and the S100A6/CacyBP/p38 signaling may provide as a promising treatment target.
机译:S100钙结合蛋白A6(S100A6)在许多恶性肿瘤中上调,并且已经鉴定了几种癌细胞中的增殖,迁移和侵袭表型的S100A6的过表达。 在本研究中,我们探讨了S100A6是否在子宫内膜异位症的发展中发挥作用。 与副骨折和正常子宫内膜组织相比,在异位子宫内膜组织中观察到S100A6的显着较高水平的mRNA和蛋白质表达。 S100A6在异位子宫内膜基质细胞(ESC)中的沉默显着抑制细胞活力,迁移和侵袭。 此外,S100A6的敲低抑制了异位胚轴中的P38 / MAPK活性,其可以通过CacyBP / SIP磷酸化抑制剂部分衰减。 总之,我们的研究结果表明S100A6的异常表达可能有助于子宫内膜异位症的发病机制,S100A6 / CacyBP / P38信号传导可以作为有前途的治疗目标提供。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号